Perspective Therapeutics (CATX) Preferred Shares Issued (2013 - 2014)
Perspective Therapeutics' (CATX) quarterly Preferred Shares Issued came in at -$9.0 in Q1 2014, up 98.75% quarter-over-quarter from -$719.0 in Q4 2013.
Perspective Therapeutics (CATX) Preferred Shares Issued (2013 - 2014) Analysis & Trends
Perspective Therapeutics has disclosed Preferred Shares Issued across 2 years of filings, most recently posting -$9.0 for Q1 2014.
- Preferred Shares Issued for Q1 2014 came in at -$9.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2014 was $1.5 million (changed N/A YoY), and the FY2014 annual result was $1.5 million, changed N/A from the prior year.
- Preferred Shares Issued came in at -$9.0 for Q1 2014 at Perspective Therapeutics, up from -$719.0 in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $1.5 million in Q3 2013 to a low of -$719.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -9.00 |
| Mar 31, 2014 | -9.00 |
| Dec 31, 2013 | -719.00 |
| Dec 31, 2013 | -719.00 |
| Sep 30, 2013 | 1.48 Mn |
| Sep 30, 2013 | 1.48 Mn |